Australia - English - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - abacavir sulfate, quantity: 351 mg (equivalent: abacavir, qty 300 mg); zidovudine, quantity: 300 mg; lamivudine, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; microcrystalline cellulose; purified water; titanium dioxide; hypromellose; indigo carmine; iron oxide yellow; macrogol 400 - trizivir is indicated in antiretroviral therapy for the treatment of human immunodeficiency virus (hiv) infected adults and adolescents over the age of 12 years. trizivir should not be administered to adults and adolescents who weigh less than 40kg because it is a fixed dose tablet, and the dose cannot be adjusted for this patient population.

Australia - English - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - lamivudine, quantity: 300 mg; dolutegravir sodium, quantity: 52.6 mg (equivalent: dolutegravir, qty 50 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate type a; povidone; mannitol; titanium dioxide; microcrystalline cellulose; sodium stearylfumarate; magnesium stearate; hypromellose; macrogol 400 - dovato (a fixed dose combination of dolutegravir and lamivudine) is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults and adolescents (from 12 years of age weighing at least 40kg): ? in antiretroviral treatment-na?ve patients with no antiretroviral treatment history who have no known or suspected resistance to either antiretroviral component; or ? to replace the current antiretroviral regimen in those who are virologically suppressed (hiv-1 rna less than 50 copies per ml) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to the integrase inhibitor class or lamivudine (see section 5.1 pharmacodynamic properties, clinical trials).

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - lamivudine, zidovudine - film-coated tablet - lamivudine 150 mg zidovudine 300 mg - antivirals for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - risedronate sodium calcium carbonate colecalciferol - film coated tablet - 35/1000/88 milligram

Malta - English - Medicines Authority

sanofi malta limited - metronidazole, spiramycin - film-coated tablet - metronidazole 125 milligram(s) ; spiramycin 750000 international unit(s) - antibacterials for systemic use

Malta - English - Medicines Authority

zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - amlodipine, valsartan - film-coated tablet - amlodipine 10 mg valsartan 160 mg - agents acting on the renin-angiotensin system

Malta - English - Medicines Authority

zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - amlodipine, valsartan - film-coated tablet - amlodipine 5 mg valsartan 160 mg - agents acting on the renin-angiotensin system

Malta - English - Medicines Authority

zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - amlodipine, valsartan - film-coated tablet - amlodipine 10 mg valsartan 160 mg - agents acting on the renin-angiotensin system

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: hyprolose; lactose monohydrate; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; purified talc - olmetec is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; purified talc - olmetec is indicated for the treatment of hypertension.